Court Upholds Blood Pressure Drug Patent

Law360, New York (July 18, 2006, 12:00 AM EDT) -- King Pharmaceuticals scored a major courtroom victory after a district court upheld a patent for its blood pressure and hypertension drug Altace.

The U.S. District Court for the Eastern District of Virginia ruled that generics maker Lupin LTD infringed the patent for the active ingredient in Altace and affirmed that the patent was valid and enforceable.

“We are pleased with the court's decision upholding the validity of King's Altace patent,” King said in a statement. “This decision reinforces the confidence we have continued to express in...
To view the full article, register now.